Evaluation of cystatin C with iohexol clearance in cardiac surgery

Acta Anaesthesiologica Scandinavica

Volumn 55, Issue 2, 2011, Pages 196-202

  Bronden B ^a   Eyjolfsson, A ^b   Blomquist, S ^a   Dardashti, A ^a   Ederoth, P ^a   Bjursten, H ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATININE; CYSTATIN C; IOHEXOL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIAGNOSTIC ACCURACY; DRUG CLEARANCE; ELECTIVE SURGERY; FEMALE; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; ANESTHESIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIAC SURGICAL PROCEDURES; CORONARY ARTERY BYPASS; CREATININE; CYSTATIN C; DATA INTERPRETATION, STATISTICAL; FEMALE; GLOMERULAR FILTRATION RATE; HEART FUNCTION TESTS; HUMANS; IOHEXOL; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; STROKE VOLUME;

EID: 78651498187     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2010.02361.x     Document Type: Article

References (33)

1. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT., Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The multicenter study of perioperative ischemia research group. Ann Intern Med 1998; 128: 194-203.
2. Stafford-Smith M., Evidence-based renal protection in cardiac surgery. Semin Cardiothorac Vasc Anesth 2005; 9: 65-76. (Pubitemid 40328237)
3. Brown JR, Cochran RP, MacKenzie TA, Furnary AP, Kunzelman KS, Ross CS, Langner CW, Charlesworth DC, Leavitt BJ, Dacey LJ, Helm RE, Braxton JH, Clough RA, Dunton RF, O'Connor GT., Long-term survival after cardiac surgery is predicted by estimated glomerular filtration rate. Ann Thorac Surg 2008; 86: 4-11.
4. Mathew TH., Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement. Med J Aust 2005; 183: 138-41.
5. Johnson D., The CARI guidelines. Evaluation of renal function. Nephrology (Carlton) 2005; 10 (Suppl. 4): S133-76.
6. Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez-Bru C, Grubb A., Cystatin C as a marker of GFR-history, indications, and future research. Clin Biochem 2005; 38: 1-8.
7. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP., Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995; 47: 312-8.
8. Dharnidharka VR, Kwon C, Stevens G., Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40: 221-6.
9. Fliser D, Ritz E., Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis 2001; 37: 79-83.
10. Nergelius G, Lidgren L, Grubb A, Vinge E., Renal dysfunction after total knee replacement is not aggravated by bone cement. Acta Anaesthesiol Scand 1998; 42: 974-81.
11. Abu-Omar Y, Mussa S, Naik MJ, MacCarthy N, Standing S, Taggart DP., Evaluation of Cystatin C as a marker of renal injury following on-pump and off-pump coronary surgery. Eur J Cardiothorac Surg 2005; 27: 893-8.
12. Ristikankare A, Poyhia R, Kuitunen A, Skrifvars M, Hammainen P, Salmenpera M, Soujaranta-Ylinen R., Serum cystatin C in elderly cardiac surgery patients. Ann Thorac Surg 89: 689-94.
13. Haase M, Bellomo R, Devarajan P, Qing M, Bennet MR, Möckel M, Matalanis G, Dragun D, Haase-Fielitz A., Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults. Ann Thorac Surg 2009; 88: 124-30.
14. Haase-Fielitz A, Bellomo R, Devarajan P, Story D, Matalanis G, Dragun D, Haase M., Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery-a prospective cohort study. Crit Care Med 2009; 37: 553-60.
15. Heise D, Waeschle RM, Schlobohm J, Wessel J, Quintel M., Utility of cystatin C for assessment of renal function after cardiac surgery. Nephron Clin Pract 2009; 112: c107-14.
16. Qing-Ping W, Jian-Wen G, Xiang-Hong Z, Hui L, Xiang-Hang L., Assessment of glomerular filtration rate by serum cystatin C in patients undergoing coronary artery bypass grafting. Ann Clin Biochem 2009; 46: 495-500.
17. Larsson A, Malm J, Grubb A, Hansson LO., Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. Scand J Clin Lab Invest 2004; 64: 25-30.
18. Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindstrom V, Grubb A., Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994; 40: 1921-6.
19. Krutzen E, Back SE, Nilsson-Ehle I, Nilsson-Ehle P., Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate. J Lab Clin Med 1984; 104: 955-61.
20. Brochner-Mortensen J., A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972; 30: 271-4.
21. Cockcroft DW, Gault MH., Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
22. Levey AS, Greene T, Kusek JW, Beck GL, Group MS., A simplified equation to predict glomerular filtration rate from serum creatinine (abstract). J Am Soc Nephrol 2000; 11: 115 A.
23. Grubb A, Nyman U, Bjork J, Lindstrom V, Rippe B, Sterner G, Christensson A., Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem 2005; 51: 1420-31.
24. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (Suppl. 1): S1-266.
25. Nilsson-Ehle P, Grubb A., New markers for the determination of GFR: iohexol clearance and cystatin C serum concentration. Kidney Int Suppl 1994; 47: S17-9.
26. O'Riordan SE, Webb MC, Stowe HJ, Simpson DE, Kandarpa M, Coakley AJ, Newman DJ, Saunders JA, Lamb EJ., Cystatin C improves the detection of mild renal dysfunction in older patients. Ann Clin Biochem 2003; 40 (Part 6): 648-55.
27. Bokenkamp A, van Wijk JA, Lentze MJ, Stoffel-Wagner B., Effect of corticosteroid therapy on serum cystatin C and beta2-microglobulin concentrations. Clin Chem 2002; 48: 1123-6.
28. Fricker M, Wiesli P, Brandle M, Schwegler B, Schmid C., Impact of thyroid dysfunction on serum cystatin C. Kidney Int 2003; 63: 1944-7.
29. Keller CR, Odden MC, Fried LF, Newman AB, Angleman S, Green CA, Cummings SR, Harris TB, Shlipak MG., Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int 2007; 71: 239-44.
30. Shlipak MG, Katz R, Cushman M, Sarnak MJ, Stehman-Breen C, Psaty BM, Siscovick D, Tracy RP, Newman A, Fried L., Cystatin-C and inflammatory markers in the ambulatory elderly. Am J Med 2005; 118: e25-1416.
31. Samouilidou EC, Grapsa E., Relationship of serum cystatin C with C-reactive protein and apolipoprotein A1 in patients on hemodialysis. Ren Fail 2008; 30: 711-5.
32. James S., Year report 2007. Swedish Coronary Angiography and Angioplasty Registry (SCAAR) 2008: 1-114.
33. Hillman K, Bishop G, Bristow P., The crystalloid versus colloid controversy: present status. BailliÃre's Clin Anaesthesiol 1997; 11: 1-13.